Atomoxetine Hydrochloride Patent Expiration

Atomoxetine Hydrochloride is Used for managing symptoms of attention-deficit hyperactivity disorder. It was first introduced by Eli Lilly And Co in its drug Strattera on Nov 26, 2002. 9 different companies have introduced drugs containing Atomoxetine Hydrochloride.

Atomoxetine Hydrochloride Patents

Given below is the list of patents protecting Atomoxetine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Strattera	US5658590 (Pediatric)	Treatment of attention-deficit/hyperactivity disorder	May 26, 2017 (Expired)	Lilly
Strattera	US5658590	Treatment of attention-deficit/hyperactivity disorder	Nov 26, 2016 (Expired)	Lilly

Atomoxetine Hydrochloride's Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Atomoxetine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Atomoxetine Hydrochloride. The first generic version for Atomoxetine Hydrochloride was by Zydus Pharmaceuticals Usa Inc and was approved on Sep 16, 2010. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Apr 5, 2023.

Given below is the list of companies who have filed for Atomoxetine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.

1. APOTEX

Apotex Inc has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 18MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 25MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 40MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 60MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 80MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 100MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017

Manufacturing Plant Locations
^New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country

City

Firm Name

United States

Weston

Apotex Corp.

Canada

Toronto	Apotex Inc.
Etobicoke	Apotex, Inc.
Richmond Hill	Apotex Inc.
Winnipeg	Apotex Fermentation Inc.
North York	Apotex Inc.
Brantford	Apotex Pharmachem Inc.

India

Bangalore	Apotex Pharmachem India Pvt Ltd.
Bangalore	Apotex Research Private Limited - Bioequivalence Centre
Bengaluru	Apotex Research Private Limited

2. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 18MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 10MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 25MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 40MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 60MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 80MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 100MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017

Manufacturing Plant Locations
^New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country

City

Firm Name

India

Medchal	Aurobindo Pharma Ltd
Polepally, Mahaboob Nagar	Aurobindo Pharma Limited
Sangareddy	Aurobindo Pharma Limited
Bachupally	Aurobindo Pharma Limited

United States

East Windsor

Aurobindo Pharma USA Inc

3. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	capsule	Prescription	ORAL	AB	Feb 23, 2018
EQ 100MG BASE	capsule	Prescription	ORAL	AB	Feb 23, 2018
EQ 80MG BASE	capsule	Prescription	ORAL	AB	Feb 23, 2018
EQ 60MG BASE	capsule	Prescription	ORAL	AB	Feb 23, 2018
EQ 40MG BASE	capsule	Prescription	ORAL	AB	Feb 23, 2018
EQ 25MG BASE	capsule	Prescription	ORAL	AB	Feb 23, 2018
EQ 18MG BASE	capsule	Prescription	ORAL	AB	Feb 23, 2018

4. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 18MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 25MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 40MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 60MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 80MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 100MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017

5. HETERO LABS LTD V

Hetero Labs Ltd Unit V has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	capsule	Prescription	ORAL	AB	Mar 11, 2021
EQ 10MG BASE	capsule	Prescription	ORAL	AB	Mar 11, 2021
EQ 18MG BASE	capsule	Prescription	ORAL	AB	Mar 11, 2021
EQ 100MG BASE	capsule	Prescription	ORAL	AB	Mar 11, 2021
EQ 80MG BASE	capsule	Prescription	ORAL	AB	Mar 11, 2021
EQ 60MG BASE	capsule	Prescription	ORAL	AB	Mar 11, 2021
EQ 40MG BASE	capsule	Prescription	ORAL	AB	Mar 11, 2021

6. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 80MG BASE	capsule	Prescription	ORAL	AB	Feb 18, 2021
EQ 10MG BASE	capsule	Prescription	ORAL	AB	Feb 18, 2021
EQ 18MG BASE	capsule	Prescription	ORAL	AB	Feb 18, 2021
EQ 25MG BASE	capsule	Prescription	ORAL	AB	Feb 18, 2021
EQ 40MG BASE	capsule	Prescription	ORAL	AB	Feb 18, 2021
EQ 60MG BASE	capsule	Prescription	ORAL	AB	Feb 18, 2021
EQ 100MG BASE	capsule	Prescription	ORAL	AB	Feb 18, 2021

Manufacturing Plant Locations
^New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country

City

Firm Name

United States

East Brunswick	Strides Pharma Inc.
Chestnut Ridge	Strides Pharma, Inc.

India

Puducherry	Strides Pharma Science Limited
Bangalore	Strides Pharma Science Limited

7. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 18MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 25MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 40MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 60MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 80MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017
EQ 100MG BASE	capsule	Prescription	ORAL	AB	May 30, 2017

8. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 18MG BASE	capsule	Prescription	ORAL	AB	Sep 16, 2010
EQ 25MG BASE	capsule	Prescription	ORAL	AB	Sep 16, 2010
EQ 40MG BASE	capsule	Prescription	ORAL	AB	Sep 16, 2010
EQ 60MG BASE	capsule	Prescription	ORAL	AB	Sep 16, 2010
EQ 80MG BASE	capsule	Prescription	ORAL	AB	Sep 16, 2010
EQ 100MG BASE	capsule	Prescription	ORAL	AB	Sep 16, 2010
EQ 10MG BASE	capsule	Prescription	ORAL	AB	Apr 5, 2023

Pharsight

Pharsight

Atomoxetine Hydrochloride Patent Expiration

Atomoxetine Hydrochloride Patents

Atomoxetine Hydrochloride's Family Patents

Explore Our Curated Drug Screens

Atomoxetine Hydrochloride Generic API Manufacturers

1. APOTEX

Manufacturing Plant Locations
^New

2. AUROBINDO PHARMA

Manufacturing Plant Locations
^New

3. DR REDDYS

4. GLENMARK PHARMS LTD

5. HETERO LABS LTD V

6. STRIDES PHARMA

Manufacturing Plant Locations
^New

7. TEVA PHARMS USA

8. ZYDUS PHARMS USA INC

Have Questions?

Pharsight

Pharsight

Atomoxetine Hydrochloride Patents

Atomoxetine Hydrochloride's Family Patents

Explore Our Curated Drug Screens

Atomoxetine Hydrochloride Generic API Manufacturers

1. APOTEX

Manufacturing Plant Locations New

2. AUROBINDO PHARMA

Manufacturing Plant Locations New

3. DR REDDYS

4. GLENMARK PHARMS LTD

5. HETERO LABS LTD V

6. STRIDES PHARMA

Manufacturing Plant Locations New

7. TEVA PHARMS USA

8. ZYDUS PHARMS USA INC

Related content

Have Questions?

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New